ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Review of molecular biological research on the treatment of membranous nephropathy with Tripterygium glycosides based on TCM theory

Xu, Pengyu; Fu, Guangchu*; Zhao, Haishen; Wang, Manya; Ye, Hong; Shi, Kejun; Zang, Pin; Su, Xubo南方医科大学; 5
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries2023-11-10DOI: 10.1097/MD.0000000000034686
23阅读
引用收藏
分享

摘要

To explore the mechanism of Tripterygium wilfordii polyglycoside (TWP) in the treatment of membranous nephropathy (MN) by network pharmacology. TCMSP and DrugBank databases were used to screen the main targets of the main active components of Tripterygium glycosides, and OMIM and Gene Cards databases were used to search the gene targets of MN. UniProt database was used to normalize all the targets to get the intersection targets of TGs and MNs. Synergistic genes were uploaded to the STRING platform to construct a protein-protein interaction network and screen related core targets. Gene Ontology and Kyoto Genome Encyclopedia analyses of core targets were performed using the DAVID database. AutoDockTools software was used to verify the molecular docking between the active components of TGs and the synergistic genes. We identified 126 potential targets for the active component of Tripterygium glycosides, 584 MN-associated disease targets, and 28 co-acting genes. It mainly involves AGE-RAGE signaling pathway, lipid and atherosclerosis, IL-17 signaling pathway, fluid shear stress and atherosclerosis, NF-kappa B signaling pathway and other pathways and biological pathways in diabetic complications. The active component of that Tripterygium glycosides and the active site of the synergistic core target can the bond energy is less than -5kJ/mol. Tripterygium glycosides can regulate the release of inflammatory factors to treat MN through multiple active components, multiple disease targets, multiple biological pathways and multiple pathways, which provides a basis for broadening the clinical use of traditional Chinese medicine in the treatment of MN.

学科与关键词

关键词
mechanism of actionmembranous nephropathynetwork pharmacologyTCM theoryTripterygium wilfordii polyglycoside
相关
加载中…
  • Identification of Taohong Siwu Decoction in Treating Chronic Glomerulonephritis Using Network Pharmacology and Molecular Docking
    Du, Guoxia; Qu, Xiaohan; Hu, Jing; Zhang, Yuzhen; Cai, Yongming*Natural Product Communications, 2022, 17(11): 1934578X221139966.
  • Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models
    Zheng, Bidan; Lu, Dongfang; Chen, Xiuping; Yin, Yinghua; Chen, Weiying; Wang, Xiaowan; Lin, Huanmei; Xu, Peng*; Wu, Aihua*; Liu, Bo*RENAL FAILURE, 2023, 45(1): 2182617.
  • Network Pharmacology-Based Investigation of the Molecular Mechanisms of the Chinese Herbal Formula Shenyi in the Treatment of Diabetic Nephropathy
    Chen, Keng; Deng, Yiyao; Shang, Shunlai; Li, Ping; Liu, Linchang*; Chen, Xiangmei*Frontiers in Medicine, 2022, 9: 898624.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
发表日期
2023-11-10
卷期
第 102 卷, 第 45 期
页码
e34686
DOI
10.1097/MD.0000000000034686
语言
ENGLISH
成果收录
SCIE

作者

  • X

    Xu, Pengyu (第一作者)

  • F

    Fu, Guangchu (通讯)

    5 · southern med univ

查看全部 8 位作者收起作者
  • Z

    Zhao, Haishen

    new

  • W

    Wang, Manya

    new

  • Y

    Ye, Hong

    new

  • S

    Shi, Kejun

    new

  • Z

    Zang, Pin

    new

  • S

    Su, Xubo

    new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417